X
Human Vaccines and Immunotherapeutics (HVI) is a scholarly journal dedicated to publishing research in the field of Pharmacology, Toxicology and Pharmaceutics, and Published by Taylor & Francis. The Print-ISSN of Human Vaccines and Immunotherapeutics is 21645515
The Publication fees (APC) is 5085 AUD; 3505 EUR; 2920 GBP; 3650 USD.
Human Vaccines and Immunotherapeutics is published by Taylor & Francis, based in United Kingdom, publishing since 2022. It covers research in Pharmacology, Toxicology and Pharmaceutics, Immunology and Microbiology, Medicine.
Topics covered include immunotherapy, immunology, epidemiology, pharmaco-economics, vaccines.
The journal is indexed in Scopus, DOAJ; it uses a anonymous peer review process.
Article processing charge: 5085 AUD; 3505 EUR; 2920 GBP; 3650 USD.
For full aims and scope, see the journal's official page.
| Journal title | Human Vaccines and Immunotherapeutics (HVI) |
| Print ISSN | 21645515 |
| Online ISSN | 2164554X |
| Publisher Name | Taylor & Francis |
| Subject Category | Pharmacology, Toxicology and Pharmaceutics |
| Access type | 🟢 Open Access |
| Status | 🟢 Active |
In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.
Below are the metrics and rankings for the journal Human Vaccines and Immunotherapeutics
| Article Publication Charges (APC) |
5085 AUD; 3505 EUR; 2920 GBP; 3650 USD ✳️Without APC Pharmacology, Toxicology and Pharmaceutics Journals |
Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars
If you would like to submit a manuscript or visit the journal's website, please click on the link below.
| Journal Submission | 🔗 Journal Website |
Add the app to your device for one-tap access.
